Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Inventory (2023 - 2024)

InflaRx's Inventory history spans 2 years, with the latest figure at $7.4 million for Q4 2024.

  • On a quarterly basis, Inventory fell 39.74% to $7.4 million in Q4 2024 year-over-year; TTM through Dec 2024 was $7.4 million, a 39.74% decrease, with the full-year FY2024 number at $7.4 million, down 39.74% from a year prior.
  • Inventory hit $7.4 million in Q4 2024 for InflaRx, down from $12.2 million in the prior quarter.
  • Over the last five years, Inventory for IFRX hit a ceiling of $12.2 million in Q4 2023 and a floor of $7.4 million in Q4 2024.